Lon­za keeps adding on as it looks to beef up bi­o­log­ics of­fer­ing, tack­ing on near­ly $1B in ex­pan­sions in EU, US

Amid a flur­ry of ex­pan­sion ac­tiv­i­ty, CD­MO Lon­za is con­tin­u­ing to beef up its man­u­fac­tur­ing plants both in its na­tive Switzer­land and in the US. The newest plan? A $935 mil­lion out­lay to build new sites in Visp and Portsmouth, NH, to help grow the com­pa­ny’s bi­o­log­ics port­fo­lio.

The Swiss plant — which will ab­sorb the vast ma­jor­i­ty of the new funds — will house six 20,000-liter biore­ac­tors as part of a 90,000-plus-square-foot foot­print. The site will be de­signed to op­ti­mize en­er­gy and wa­ter ef­fi­cien­cy and cost about $714 mil­lion, Lon­za said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER